ITC investigates Chongqing over medical devices
Washington DC | 12 February 2016

The US International Trade Commission (ITC) has instituted an investigation of Chongqing QMI Surgical medical devices on behalf of Covidien.

The ITC announced its investigation on 10 February, following a request from Covidien in its recent complaint against the China-based device maker.

Covidien filed a complaint with the ITC against Chongqing on 8 January, alleging that the Chinese device maker unlawfully imports surgical devices that infringe two of its patents.

The complaint identifies Chongqing’s QELC Universal Endoscopic Linear Cutting Stapler and Loading Units as infringing products.

Covidien asked the ITC to issue a limited exclusion order and a cease and desist order, preventing Chongqing importing the device staplers that allegedly infringe its patents.

The ITC said in a statement that its chief administrative judge will assign the case to one of its administrative law judges, who will hold an evidentiary hearing.

It will make a “final determination” in the investigation at the earliest practicable time.

Author: Tammy Facey

More IPPro Life Sciences | latest news
AstraZeneca enters China with Plendil
Hogan Lovells boosts capabilities in Japan
Morgan Lewis bags four from K&L Gates
Cobra and CPI enter £1.8 million project
Doctors Without Borders urges lower vaccine prices
IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization